Eduardo Rene Salas

Insider Reports History

Location
Bedminster, NJ
Signature
/s/ Eduardo Rene Salas, by Michael A. Goldstein as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eduardo Rene Salas:

Company Role Class Num Shares Value Price $ Report Date Ownership
ADMA BIOLOGICS, INC. Director Common Stock 21,579 $386,911 $17.93 09 Feb 2026 Direct
ADMA BIOLOGICS, INC. Director Stock Option (Right to Buy) 17,730 $59,581 $3.66 09 Feb 2026 Direct
Intra-Cellular Therapies, Inc. Director Common Stock 0 $0 $132.00 02 Apr 2025 Direct
Intra-Cellular Therapies, Inc. Director Restricted Stock Units 0 $0 $132.00 02 Apr 2025 Direct
Intra-Cellular Therapies, Inc. Director Stock Option (right to buy) 0 02 Apr 2025 Direct

Insider Reports Filed by Eduardo Rene Salas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADMA ADMA BIOLOGICS, INC. 09 Feb 2026 2 $0 4 Director 11 Feb 2026, 21:00
ITCI Intra-Cellular Therapies, Inc. 02 Apr 2025 6 -$206,844 4 Director 02 Apr 2025, 20:34
ADMA ADMA BIOLOGICS, INC. 19 Feb 2025 2 $0 4 Director 21 Feb 2025, 21:05
ADMA ADMA BIOLOGICS, INC. 30 Dec 2024 1 $0 4 Director 02 Jan 2025, 16:15
ADMA ADMA BIOLOGICS, INC. 30 Dec 2024 0 $0 3 Director 02 Jan 2025, 16:10
ITCI Intra-Cellular Therapies, Inc. 23 Jun 2024 2 $0 4 Director 25 Jun 2024, 18:05
ITCI Intra-Cellular Therapies, Inc. 14 Jun 2024 2 $0 4 Director 18 Jun 2024, 18:02
ITCI Intra-Cellular Therapies, Inc. 23 Jun 2023 2 $0 4 Director 27 Jun 2023, 17:12
ITCI Intra-Cellular Therapies, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 17:03
ITCI Intra-Cellular Therapies, Inc. 20 Apr 2022 1 $0 4 Director 21 Apr 2022, 16:54
ITCI Intra-Cellular Therapies, Inc. 20 Apr 2022 0 $0 3 Director 21 Apr 2022, 16:52